A CRISPR picture – what to expect from the gene-editing patent boom
The big increase in CRISPR patent filing has led to a number of disputes as well as suggested cross-licensing agreements or patent pools. Patrick Wingrove investigates whether a litigation war is brewing
The gene-editing technology called clustered regularly interspaced palindromic repeats (CRISPR) has recently attracted a lot of patent filings.
According to iRunway’s 2018 CRISPR: Global Patent Landscape report, 4,706 patents were filed globally in 2015, which represents a 3492% rise...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.